Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table1_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.DOCX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Mechanisms through which IAS may increase disease risk: Real-case examples. حسب Eleonora Chinchio (9553057)

Results on the trimmed datasets with a decreasing number of papers per author available for training and testing. حسب Leonard Bauersfeld (16475015)

Summary of the care task groups programmed into the DES model and their task duration, priority rank, and sensitivity to COVID-19 where C+ = COVID+ patients; C- = non-COVID patient... حسب Sadeem Munawar Qureshi (8705436)

Summary characteristics of cases and controls. حسب EDITH BAM (19948656)

الموضوعات:

Classification of the emergent synchronization patterns when stimulating a single brain region for three different cases. حسب Andrew Patton (10224161)

Traumatic atlantoaxial subluxation, posterior transfacet fixation: a case report حسب Mario Cahueque Lemus (10417498)

"…<div><p>Cervical spine injuries are often described as catastrophic events in neurological terms, with very low survival rate. Lesions to C3-C7 segment are the most common (about 80%) followed by segment C1-C2 (20%). …"

LDL-C target attainment in the total cohort and stratified by risk as observed and simulated. حسب Julius L. Katzmann (10960479)

الموضوعات:

Ribosomal protein subunit large (Rpl) and small (Rps) transcripts are expressed at decreased levels at the site of <i>L</i>. <i>major</i> infection. حسب Gopinath Venugopal (638444)

Decreased glycosylated α-DG and laminin levels distal to the glial dome in <i>Large</i>^{<i>myd/myd</i>} mice. حسب Shigefumi Morioka (8893511)

Malaria cases exported from the Yanomami indigenous land. حسب Marcia C. Castro (7377455)

Best ITDs of MSO neurons shift to the ecological ITD range during development. حسب Martijn C. Sierksma (11608174)

Distribution of IBD cases normalised by population across the UK according to the postcode at first diagnosis: (a) CD, (b) UC and (c) all IBD cases. حسب Mehmet A. Veral (22138919)

Statins resulted in smaller neuronal soma size. حسب Shuk C. Tsoi (21192243)

"…Areas of cell somas in the heterogeneous BrdU-/Hu+ group are significantly smaller in the statin-treated (light blue line) group compared to soma areas in controls (dark blue line, bottom panel). Statin treatment decreased cell sizes in the larger cells more than in the smaller cells as seen in the greater divergence between lines plotted for larger cell somas (bottom panel). …"

ECoG timescales decrease during spatial attention. حسب Isabel Raposo (21615517)